Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Compass Pathways
Biotech
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Metabolic disorder biotech lands industry vet as CMO. MaaT welcomes ex-Autolus leader. Former Seagen execs take Shape.
Gabrielle Masson
,
Andrea Park
Jun 28, 2024 8:30am
Compass tracks PTSD improvements in midphase psilocybin trial
May 8, 2024 8:07am
Compass, Hackensack Meridian ink research deal for psilocybin
Jan 17, 2024 10:53am
Compass shows safety in first psilocybin trial for PTSD
Dec 20, 2023 7:26am
Data on psilocybin in anorexia point Compass to new opportunity
May 3, 2022 8:33am
Psilocybin clears biggest test yet, easing depression in phase 2
Nov 10, 2021 7:30am